Biotech Snap

Biotech Snap

A daily 5-min biotech briefing

Latest news

Daily Snap - 14. August 2025

Daily Snap - 14. August 2025

Joachim Eeckhout
Response’s RDX-002 shows promise for keeping weight off after GLP-1 drugs

Response’s RDX-002 shows promise for keeping weight off after GLP-1 drugs

Eduardo Longoria
Vor’s pivot to autoimmune drugs gains traction with Sjögren’s trial success

Vor’s pivot to autoimmune drugs gains traction with Sjögren’s trial success

Eduardo Longoria
Bayer bets $1.3B on Kumquat's KRAS inhibitor cancer drug

Bayer bets $1.3B on Kumquat's KRAS inhibitor cancer drug

Joachim Eeckhout
FDA approves Insmed’s Brinsupri, the first DPP1 inhibitor on the market

FDA approves Insmed’s Brinsupri, the first DPP1 inhibitor on the market

Joachim Eeckhout
Daily Snap - 12. August 2025

Daily Snap - 12. August 2025

Joachim Eeckhout
IO Biotech eyes FDA nod for skin cancer vaccine despite narrow trial miss

IO Biotech eyes FDA nod for skin cancer vaccine despite narrow trial miss

Joachim Eeckhout
Novartis scores a Phase 3 win in Sjögren’s syndrome, salvaging value from its $2.9B MorphoSys buy

Novartis scores a Phase 3 win in Sjögren’s syndrome, salvaging value from its $2.9B MorphoSys buy

Joachim Eeckhout
Daily Snap - 11. August 2025

Daily Snap - 11. August 2025

Joachim Eeckhout
Gilead axes 3 drug programs, including Novo-partnered MASH treatment

Gilead axes 3 drug programs, including Novo-partnered MASH treatment

Joachim Eeckhout
BioNTech settles $870M patent dispute with CureVac, clearing path for $1.25B buyout

BioNTech settles $870M patent dispute with CureVac, clearing path for $1.25B buyout

Joachim Eeckhout
Daily Snap - 8. August 2025

Daily Snap - 8. August 2025

Joachim Eeckhout
FirstBack
12345
Next Last